Answers are grounded in this paper and cite their sources.
This meta-analysis found that patients with psoriasis who smoke or have a history of smoking, as well as those with previous exposure to biologics, older age, or higher BMI, exhibited poorer response to biologics in observational studies. However, it remains unclear whether these clinical characteristics influence treatment response differently for the different biologics available for psoriasis.
No takes yet. Share an insight, caveat, or question.
Hjort et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: